Prognostic prediction of primary biliary cirrhosis and therapy monitoring with ursodeoxycholic acid / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
;
(12): 82-84, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-489076
ABSTRACT
Primary biliary cirrhosis (PBC) is a chronic cholestic autoimmune liver disease and ursodeoxycholic acid (UDCA) is the first-line drug for the treatment.Currently there are several standards applied for the prognostic and therapeutic predictions of PBC,as well as for the guidance of personalized treatment.This paper elucidated the prognostic predicting factors in PBC and their applications in therapy monitoring with UDCA.Current challenges and future research interests are also put forward.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Guía de Práctica Clínica
/
Estudio pronóstico
Idioma:
Chino
Revista:
Chinese Journal of Laboratory Medicine
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS